London · Delayed Price · Currency is GBP · Price in EUR AB Science Statistics
Total Valuation
AB Science has a market cap or net worth of GBP 84.52 million. The enterprise value is 96.75 million.
| Market Cap | 84.52M |
| Enterprise Value | 96.75M |
Important Dates
The next estimated earnings date is Friday, May 8, 2026.
| Earnings Date | May 8, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 66.18M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +9.43% |
| Shares Change (QoQ) | +6.32% |
| Owned by Insiders (%) | 31.11% |
| Owned by Institutions (%) | 0.00% |
| Float | 27.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 96.01 |
| PB Ratio | -3.61 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -13.22 |
| EV / Sales | 108.15 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -15.94 |
Financial Position
The company has a current ratio of 0.67
| Current Ratio | 0.67 |
| Quick Ratio | 0.64 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.69 |
| Interest Coverage | -4.57 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -14.79% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -184.71% |
| Weighted Average Cost of Capital (WACC) | 10.69% |
| Revenue Per Employee | 24,454 |
| Profits Per Employee | -203,321 |
| Employee Count | 36 |
| Asset Turnover | 0.05 |
| Inventory Turnover | 0.44 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -14.63% in the last 52 weeks. The beta is 1.38, so AB Science's price volatility has been higher than the market average.
| Beta (5Y) | 1.38 |
| 52-Week Price Change | -14.63% |
| 50-Day Moving Average | 1.33 |
| 200-Day Moving Average | 1.32 |
| Relative Strength Index (RSI) | 44.51 |
| Average Volume (20 Days) | 1,684 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AB Science had revenue of GBP 880,337 and -7.32 million in losses. Loss per share was -0.13.
| Revenue | 880,337 |
| Gross Profit | 798,904 |
| Operating Income | -4.48M |
| Pretax Income | -7.32M |
| Net Income | -7.32M |
| EBITDA | -4.03M |
| EBIT | -4.48M |
| Loss Per Share | -0.13 |
Balance Sheet
The company has 4.32 million in cash and 16.36 million in debt, with a net cash position of -12.04 million.
| Cash & Cash Equivalents | 4.32M |
| Total Debt | 16.36M |
| Net Cash | -12.04M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -23.42M |
| Book Value Per Share | -0.35 |
| Working Capital | -5.20M |
Cash Flow
In the last 12 months, operating cash flow was -5.90 million and capital expenditures -174,010, giving a free cash flow of -6.07 million.
| Operating Cash Flow | -5.90M |
| Capital Expenditures | -174,010 |
| Free Cash Flow | -6.07M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 90.75% |
| Operating Margin | -509.15% |
| Pretax Margin | -831.45% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AB Science does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.43% |
| Shareholder Yield | -9.43% |
| Earnings Yield | -8.66% |
| FCF Yield | -7.18% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |